School of Medicine
Showing 1-100 of 121 Results
-
Deborah Alcorn, MD
Associate Professor of Ophthalmology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsGene linkage - tuberous sclerosis; stabismus and, molteno implants; congenital stationary night blindness
-
Tayyeba K. Ali, MD
Adjunct Clinical Associate Professor, Ophthalmology
BioTayyeba K. Ali, MD, a Board Certified ophthalmologist, specializes in complex corneal disease and uveitis. She sees patients at Palo Alto Medical Foundation / Sutter Health in Sunnyvale, CA. Dr. Ali also works as a medical specialist on contract for Google.
Prior to completing two fellowships in cornea, external disease, refractive surgery and uveitis at Bascom Palmer Eye Institute, ranked #1 eye hospital in the United States by U.S. News & World Report, Dr. Ali finished her ophthalmology residency at the Jones Eye Institute / UAMS. She earned her medical degree from Emory University School of Medicine and completed her undergraduate training in English literature and creative writing from Agnes Scott College.
Dr. Ali has received many academic and teaching awards including the Bascom Palmer Fellow of the Year Award and the Jone’s Eye Dean’s Faculty Award. She has delivered dozens of lectures on the national and international level and published numerous meeting abstracts and peer-reviewed journal articles.
As a second generation American, Tayyeba finds herself dwelling on migrant and refugee stories, their need for ethnic and religious identity, and the repercussions of these journeys. She is keenly interested in international medicine, resident education, health technology and taking a closer look at the moral crossroads we face in healthcare. She is the Associated Director for Pegasus Physician Writers at Stanford as well as the Senior Fiction Editor for the medical literary magazine, The Pegasus Review; she has a particular affinity for colons (grammatically, not anatomically, speaking) and semicolons. -
Jill Beyer, OD
Clinical Assistant Professor, Ophthalmology
BioJill Beyer, OD, is a Clinical Assistant Professor at Stanford University School of Medicine.
Dr. Beyer graduated from Southern California College of Optometry, earning her Doctor of Optometry degree with distinction. She completed her residency at New England College of Optometry in Boston, Massachusetts, and earned a Bachelor of Science degree in Biology from Oregon State University.
Jill’s residency education included time spent at the Boston Foundation for Sight, Massachusetts Eye and Ear Infirmary, Cornea Consultants & Boston Laser Center, and Harvard Vanguard Medical Associates.
After residency training, Jill continued on as a clinical preceptor at the New England College of Optometry while working in private practice in Boston. She then transitioned to full time academic work at the Massachusetts Eye and Ear Infirmary becoming the Director of the Contact Lens Department and an Instructor in Ophthalmology at Harvard Medical School. -
Mark S. Blumenkranz, MD, MMS
H. J. Smead Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsClinical Interest and Research
My primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. I have been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation. I have been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.
Administrative and Community Service
I have served on the Board of Directors of a variety of voluntary education and service organizations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organizations. -
Robert Chang, MD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsI'm interested in developing a best in class glaucoma registry, utilizing modern algorithm techniques on imaging, text, and biologic data for precision health predictive analytics in glaucoma diagnosis and treatment, validating new medical devices and technologies, especially portable ones, and working on implementation science
-
E.J. Chichilnisky
John R. Adler Professor, Professor of Neurosurgery and of Ophthalmology and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsFunctional circuitry of the retina and design of retinal prostheses
-
Diana Do, MD
Professor of Ophthalmology
Current Research and Scholarly InterestsDr. Do's research focuses on collaborative clinical trials to investigate novel treatments for retinal vascular diseases and ocular inflammation. She performs research to develop state of the art therapies for age-related macular degeneration, diabetic eye disease, retinal vein occlusion, retinal inflammation, and retinal detachment.
-
Alfredo Dubra, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsOur lab seeks to help the early diagnosing and monitoring progression of ocular, vascular, neurodegenerative and systemic diseases through novel non-invasive optical ophthalmic imaging. We pursue this goal through a multidisciplinary approach that integrates optics, computer science, vision science, electrical engineering and other engineering disciplines.
-
Peter R. Egbert, MD
Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsOcular pathology of shaken baby syndrome
-
Ann Caroline Fisher, MD
Clinical Associate Professor, Ophthalmology
BioCaroline Fisher, MD, is a Clinical Associate Professor of Ophthalmology at Stanford University Hospital and Clinics. She specializes in cataract and glaucoma surgery, including minimally invasive glaucoma surgery.
She completed her undergraduate education at Stanford University, obtaining both a Bachelor of Science degree in Biology and a Bachelor of Arts degree in Spanish, with Departmental Honors. She earned her medical degree from Stanford University School of Medicine and then went on to her internship at the University of Pennsylvania Presbyterian Hospital. She completed her ophthalmology residency at NYU/ Manhattan Eye, Ear, Throat Hospital. She then returned to Stanford for her Glaucoma Fellowship.
Dr. Fisher is Director of the Stanford Belize Vision Clinic, dedicated to promoting eye health and care in Belize, and providing an international rotation for Stanford Ophthalmology Residents. She is also an Office of Faculty Development and Diversity Liaison and is currently one of the Stanford Network for Advancement and Promotion (SNAP) Cohort Leaders. Dr. Fisher is the Director of Diversity, Equity, and Inclusion for the Department of Ophthalmology. -
Michael W. Gaynon, MD
Clinical Professor, Ophthalmology
Current Research and Scholarly Interests-Retinal Vascular Disease
-Angiogenesis
-Retinopathy of Prematurity
-Sustained Release Drug Delivery Systems -
Jeffrey Goldberg, MD, PhD
Blumenkranz Smead Professor
Current Research and Scholarly InterestsLab research on molecular mechanisms of survival and regeneration in the visual system; retinal development and stem cell biology; nanoparticles and tissue engineering. Clinical trials in imaging, biomarker development, and neuroprotection and vision restoration in glaucoma and other neurodegenerative diseases.
-
Mary Elizabeth Hartnett
Michael F. Marmor, M.D. Professor of Retinal Science and Disease and Professor of Ophthalmology
BioMary Elizabeth Hartnett, MD, is the Michael F. Marmor, M.D. Professor in Retinal Science and Diseases and is a Professor of Ophthalmology at Stanford University. Dr. Hartnett is the director of Pediatric Retina at Stanford University and principal investigator of a retinal angiogenesis laboratory, in which she studies causes and treatments for diseases including retinopathy of prematurity and age-related macular degeneration. She created the first-ever academic textbook on the subject, Pediatric Retina, in its third edition, which has proven to be an invaluable resource for residents and ophthalmologists internationally.
Dr. Hartnett’s NIH-funded laboratory of vascular biology and angiogenesis has studied mechanisms causing pathology in age-related macular degeneration (AMD) and retinopathy of prematurity (ROP). Her work in AMD has been to understand the mechanisms involved in activation and invasion of choroidal endothelial cells anterior to the RPE in order to maintain vasculature that is physiologic and not damaging beneath the RPE. Her lab has elucidated environmental stressors that lead to scarring in the macula for which no vision improvement is currently possible. The goal is to find methods to prevent the scarring.
Her lab’s work in ROP provided the proof of concept to regulate an angiogenic signaling pathway by inhibiting VEGF to facilitate intraretinal neovascularization as well as to inhibit abnormal extraretinal neovascularization and reduce retinal destruction used in previous treatments. Her work has been translated through clinical trials to lead to new treatments for severe ROP and has represented a paradigm shift in the understanding and treatment of severe ROP.
Dr. Hartnett has received numerous awards, including the Weisenfeld Award, the highest award for clinician-scientists given by the Association for Research in Vision and Ophthalmology (ARVO), in 2018, and is an ARVO Gold Fellow. She received the 2019 Paul Kayser/Retina Research Foundation Global Award, the Macula Society’s 2016 Paul Henkind Award and its 2019 Arnall Patz Medal, the Paul Kayser/RRF Global Award from the PanAmerica Society, and the 2021 Suzanne Veronneau-Troutman Award, the most prestigious award from Women in Ophthalmology. In 2022, she was one of six at the University of Utah to receive a distinguished research award, for Pediatrics and Ophthalmology.
Dr. Hartnett's prolific publication record includes 227 articles in peer-reviewed journals and over 40 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, as a mentor for the ARVO Leadership Development Program, and in leadership positions internationally as chair of the research advisory committees for The Macula Society and the Jack McGovern Coats Disease Foundation as well as Chair of the Credentialing Committee for The Retina Society. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOne, Molecular Vision, and the American Journal of Ophthalmology. Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of the Association for Research in Vision and Ophthalmology (FARVO). -
Natalie Anne Homer, MD
Assistant Professor of Ophthalmology (Research/Clinical Trials)
BioDr. Homer completed her ophthalmology residency at Massachusetts Eye and Ear Infirmary at Harvard Medical School and subsequently received fellowship training in plastic and reconstructive surgical procedures of the eyelids, orbit, nasolacrimal system and face accredited by the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) at TOC Eye and Face in Austin, TX. She completed an additional fellowship year in facial cosmetic surgery through the American Academy of Cosmetic Surgery (AACS), training in procedures including rhytidectomy (facelift), platysmaplasty (necklift), forehead/brow lift, blepharoplasty (upper and lower eyelid lift) and autologous fat transfer. She served as an assistant profession in the UC Davis Department of Ophthalmology from 2020 – 2022.
Dr. Homer clinically provides comprehensive ophthalmic plastic and reconstructive surgical care to her patients. She also enjoys improving patient confidence and self-esteem through restorative cosmetic facial surgery. In addition to clinical care, Dr. Homer strives to educate and inspire young medical trainees as an assistant professor of ophthalmology.
Dr. Homer has performed research in the areas of orbital oncology, orbital and facial trauma, periorbital infections, eyelid and facial reconstruction, facial nerve palsy, pediatric orbital and adnexal disorders, nasolacrimal surgery, thyroid eye disease, cosmetic and functional surgical outcomes, wound healing, and oculoplastic fellowship education. She has presented her work at national and international conferences. In addition to her scientific work, she published 6 invited articles on topics including the women in cosmetic surgery, ophthalmology advocacy and oculoplastic fellowship training. Administratively, she serves as an Editorial Board Member for the American Journal of Ophthalmology case reports. -
Yang Hu, MD, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsThe ultimate goal of the laboratory is to develop efficient therapeutic strategies to achieve CNS neural repair, through promoting neuroprotection, axon regeneration and functional recovery.
More specifically, we study retinal ganglion cell (RGC) and optic nerve in various optic neuropathies including traumatic, glaucomatous and inflammatory optic nerve injuries to fully understand the molecular mechanisms of CNS neurodegeneration and axon regeneration failure. -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
Irmak Karaca
Instructor, Ophthalmology
BioIrmak Karaca joins the Byers Eye Institute as she is the recipient of the International Council of Ophthalmology, Retina Research Foundation Helmerich One-Year Fellowships Award in 2020. She is a visiting ophthalmologist from Turkey, and currently working as a Clinical Research Fellow with Dr. Do and Dr. Nguyen in the fields of Retina and Uveitis at Stanford. Dr. Karaca also becomes a fellow of both International Council of Ophthalmology and European Board of Ophthalmology in 2018. Dr. Karaca completed her residency at Ege University, Department of Ophthalmology in 2018 and graduated from Hacettepe University, School of Medicine in 2013 in Turkey.
Dr. Karaca also participated in nationally funded research projects during her residency. Thereby, she had significant contributions on serving the latest technology and treatment modalities to her patients in Turkey, as well as carrying out many new research studies for the scientific field. Besides, she loves performing surgeries as she believes that this is an outstanding chance for her patients to restore their vision. -
Khizer Khaderi MD, MPH
Clinical Associate Professor, Ophthalmology
BioDr. Khizer Khaderi is Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Director/Founder of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC), and faculty at the Stanford Institute for Human-Centered AI.
Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. He founded Vizzario Inc, a perceptual AI company, spun out from HPL. Khaderi has extensive domain expertise in artificial intelligence (AI), virtual reality (VR), augmented reality (AR), mixed reality (MxR), wearables, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems for the metaverse based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building collaborative partnerships across academia and industry.
Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including the Global Esports Federation, Magic Leap, Riot Games, Intel, Activision, Unity, Epic Games, Google, FB, Microsoft, Apple, NBA, Aerie Pharma, the World Health Organization, and the World Bank. -
Euna Koo, MD
Clinical Associate Professor, Ophthalmology
Clinical Assistant Professor (By courtesy), PediatricsBioDr. Koo is an ophthalmologist specializing in pediatric ophthalmology, retinopathy of prematurity (ROP) and adult strabismus. She received her ophthalmology training at UC San Francisco and then her fellowship training in pediatric ophthalmology and adult strabismus at Boston Children's Hospital affiliated with Harvard Medical School. She has been board certified by the American Board of Ophthalmology since 2016. Her practice reflects her clinical interests in pediatric ophthalmology (strabismus, amblyopia, pediatric cataracts, and ROP) and in adult strabismus.
She utilizes Botox in management of adult and pediatric strabismus. She also uses hidden adjustable sutures in children and adults to optimize alignment of eyes with surgery. Muscles can be adjusted up to 7-10 days after surgery.
She also has an interest in teaching medical students and residents and improving surgical training. -
Edward Korot
Adjunct Clinical Instructor, Ophthalmology
BioI’m a vitreoretinal surgeon guided by the goal of maximally scaling improvements in patients’ lives through technology.
My work involves medical AI validation, guideline development, safety, quantifying model uncertainty, AI-driven pharmaceutical trial recruitment, partner management, and UX research.
Currently, I’m an adjunct faculty at Stanford, and practicing in Michigan. When not working, you can find me doing yoga, practicing drone photography and playing tennis. -
Andrea Lora Kossler, MD, FACS
Assoc Professor of Ophthalmology
Current Research and Scholarly InterestsThyroid Eye Disease
Adenoid Cystic Carcinoma of the Lacrimal Gland
Lacrimal Gland Stimulation for the Treatment of Dry Eyes
Neurostimulation
Orbital Tumors
Floppy Eyelid Syndrome and Obstructive Sleep Apnea -
Scott R. Lambert, MD
Professor of Ophthalmology and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMy research has focused on improving the visual outcomes of children with congenital cataracts. I organized a randomized clinical trial, the Infant Aphakia Treatment Study to compare the visual outcomes of infants optically corrected with a contact lens vs. an intraocular lens after unilateral cataract surgery. A second area of research has been ocular growth after cataract surgery.
-
Wen-Shin Lee, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Wen-Shin Lee, MD, is a Clinical Assistant Professor of Ophthalmology at the Stanford University School of Medicine, and the Clinic Chief and Medical Director of the Byers Eye Institute Tri-Valley.
Dr. Lee is a fellowship trained, board certified ophthalmologist with expertise in the medical and surgical management of glaucoma, cataracts, and anterior segment disease. Working with patients to provide individually tailored treatment plans, he incorporates the full spectrum of conventional and minimally invasive glaucoma surgeries. He also performs complex and refractive cataract surgery utilizing advanced technology intraocular lenses. His goal is to provide the highest level of care to each patient with evidence-based medicine and cutting-edge technology.
In addition to his clinical practice, Dr. Lee is actively involved in clinical research and education at the Stanford University School of Medicine. He is a principal investigator and co-investigator on multiple clinical trials and research studies with a focus on glaucoma. He is the resident glaucoma rotation director for the Stanford ophthalmology residency and co-director of the Bay Area Ophthalmology Course. He has developed and leads microsurgical training programs for medical students, residents, and fellows at Stanford. In addition, he serves on the Education Committee and Clinical Competency Committee for the Stanford Department of Ophthalmology.
Dr. Lee was educated at the University of California, Berkeley, where he graduated summa cum laude with a degree in molecular and cell biology. He then received his medical degree at Harvard Medical School, followed by his ophthalmology residency at the Stanford University School of Medicine, and glaucoma fellowship at the Jules Stein Eye Institute at UCLA. Upon completion of his training he joined the clinical faculty at Stanford.
Dr. Lee serves as the Clinic Chief and Medical Director of the Byers Eye Institute Tri-Valley, where his goal is to deliver world class eye care to the Tri-Valley region and beyond. -
Theodore Leng, MD, FACS
Associate Professor of Ophthalmology and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult MSD)
Current Research and Scholarly InterestsDr. Leng was the first surgeon in California to perform a subretinal transplant of adult neural stem cells into patients with macular degeneration and is actively researching cellular, biologic and laser-based therapies for macular degeneration. He also has an active program in imaging informatics and deep learning to perform big data analyses of retinal scans to identify patients who are at risk for retinal disease deterioration. The end goal is earlier detection and rapid treatment to maximize visual outcomes.
Dr. Leng is considered a leading expert on optical coherence tomography (OCT) and OCT-based angiography (OCTA), a non-invasive and non-contact imaging technique for the retina. He is also considered a key opinion leader in artificial intelligence and data science. -
Y. Joyce Liao, MD, PhD
Professor of Ophthalmology and of Neurology
Current Research and Scholarly InterestsIschemic optic neuropathy
Stem cell transplantation
Optic neuropathy
Optic neuritis
Eye movement disorders
Reading
Parkinson's disease
Multiple sclerosis -
Charles C. Lin, MD
Clinical Associate Professor, Ophthalmology
Current Research and Scholarly InterestsDr. Lin conducts clinical trials focused on cornea transplantation, corneal edema, and cornea infections at Stanford. His research interests include improving the success and safety of cutting edge surgeries such as ultra-thin DSAEK, DMEK, DALK, and DSO. He is actively researching surgical therapies for corneal edema and Fuchs' Dystrophy. He is among a handful of cornea specialists nationwide with extensive experience using intraoperative OCT imaging to perform cornea transplants.
-
Wendy Liu, MD, PhD
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsDr. Liu's research interests include the role of mechanosensation in the eye as it relates to the pathophysiology of glaucoma, with the goal of finding new druggable targets in glaucoma treatment.
-
Cassie Ann Ludwig, MD, MS (she/her/hers)
Assistant Professor of Ophthalmology (Research/Clinical Trials)
Current Research and Scholarly InterestsMy research at present focuses on better understanding high and pathologic myopia and their retina sequelae (retinal detachments, myopic traction maculopathy, myopic macular degeneration) through informatics and data-driven research. My goal is to make discoveries within the field of Ophthalmology that will impact the rest of medicine, taking advantage of our ready access to the only visible portion of the central nervous system.
-
Vinit B. Mahajan, MD, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsOur focus is the development of personalized medicine for eye diseases through translation of our discoveries in proteomics, genomics, and phenomics in humans, mice and tissue culture models.
-
Edward Manche, MD
Professor of Ophthalmology
BioEdward E. Manche, MD is Professor of Ophthalmology and Director of the Cornea and Refractive Surgery Service at Stanford University School of Medicine. He received his medical degree from Albert Einstein College of Medicine and completed residency training at the University of Medicine and Dentistry at New Jersey where he served as Chief Resident. He completed a two-year fellowship in Cornea and Refractive Surgery at the Jules Stein Eye Institute at UCLA.
Dr. Manche is a fellow of the American Academy of Ophthalmology and received its Achievement Award in 2003 and its Senior Achievement Award in 2014. He was elected to active membership in the American Ophthalmological Society in 2011, and is recognized in Best Doctors in America and Guide to America's Top Physicians. He serves on the editorial boards of the American Journal of Ophthalmology, Journal of Ophthalmology, Clinical and Experimental Ophthalmology and Journal of Refractive Surgery.
He lectures widely on topics in cornea and refractive surgery and has published over 130 peer-reviewed articles and 30 book chapters. -
Michael Marmor, MD
Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsResearch concerns diseases of retinal function, techniques of clinical electrophysiology, and experimental studies on retinal pigment epithelial (RPE) function including fluid transport and retinal adhesiveness. Other studies consider aspects of vision and art, and ophthalmic history.
Published over 300 journal articles, chapters, books (only selected articles listed). -
Artis A. Montague, MD, PhD
Clinical Professor, Ophthalmology
Current Research and Scholarly InterestsMulticenter Catalys Consortium Trial - To compare femtosecond laser assisted cataract surgery with conventional cataract surgery
-
Darius M. Moshfeghi, MD
Professor of Ophthalmology
Current Research and Scholarly InterestsDr. Moshfeghi leads the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP network) and the Pediatrix-Stanford collaboration TeleROP. Between these 2 screening programs, nearly 2% of United States neonatal intensive care units are being provided telemedicine screening services through Stanford University.
-
Heather E. Moss, MD, PhD
Associate Professor of Ophthalmology and of Neurology
Current Research and Scholarly InterestsI am a clinician scientist with a background in engineering, epidemiology and neuro-ophthalmology. In my research, I combine tools from these disciplines with the goal of understanding and preventing vision loss from optic nerve diseases. My focus is on papilledema, the swelling of the optic nerve head due to elevation in intracranial pressure, which we are characterizing using electrophysiological and imaging techniques. Other areas of interest are peri-operative vision loss and optic neuritis.
-
Prithvi Mruthyunjaya, MD, MHS
Professor of Ophthalmology and, by courtesy, of Radiation Oncology
Current Research and Scholarly InterestsDr Mruthyunjaya has maintained a broad research interest with publications in both ocular oncology and retinal diseases.
His focus is on multi-modal imaging of ocular tumors and understanding imaging clues that may predict vision loss after ocular radiation therapy. He coordinates multi-center research on the role of genetic testing and outcomes of treatments of ocular melanoma.
In the field of retinal diseases, his interests are in intra-operative imaging to enhance surgical accuracy. -
David Myung, MD, PhD
Associate Professor of Ophthalmology and, by courtesy, of Chemical Engineering
Current Research and Scholarly InterestsNovel biomaterials to reconstruct the wounded cornea
Mesenchymal stem cell therapy for corneal and ocular surface regeneration
Engineered biomolecule therapies for promote corneal wound healing
Telemedicine in ophthalmology -
Ramsudha Narala
Clinical Assistant Professor, Ophthalmology
BioDr. Ramsudha Narala is a board certified ophthalmologist who specializes in vitreoretinal surgery and ocular oncology. Dr. Narala grew up in Fresno, California and following high school, she attended the 8 year combined undergraduate-medical school program at Saint Louis University in Saint Louis, Missouri.
After medical school, she completed her ophthalmology residency at Kresge Eye Institute in Detroit, MI, where she received the best resident teacher award and highest resident ophthalmic knowledge assessment program exam score award. She then joined the University of Southern California in Los Angeles, California for a 2 year vitreoretinal surgery fellowship where she was elected chief vitreoretinal surgery fellow. Following completion of vitreoretinal surgery fellowship, she pursued an advanced training fellowship in ocular oncology at Byers Eye Institute at Stanford University.
Dr. Narala has authored many peer-reviewed scientific publications and textbook chapters on vitreoretinal diseases and ocular oncology. She is also dedicated to education and teaching medical students, residents, and fellows.
Dr. Narala's clinical practice is mainly based at Santa Clara Valley Medical Center. -
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders. -
Daniel Palanker, PhD
Professor of Ophthalmology and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsInteractions of electric field and light with biological cells and tissues and their applications to imaging, diagnostics, therapeutics and prosthetics, primarily in ophthalmology.
Specific fields of interest:
Electronic retinal prosthesis;
Electronic enhancement of tear secretion;
Electronic control of blood vessels;
Non-damaging retinal laser therapy;
Ultrafast laser surgery;
Interferometric imaging of neural signals;
Cell transplantation and retinal plasticity. -
Carolyn Pan, MD
Clinical Associate Professor, Ophthalmology
BioDr. Pan is a board-certified ophthalmologist and fellowship-trained vitreoretinal surgeon. She focuses on retinal vascular diseases, macular degeneration, and surgical repair of retinal detachments, macular pathology, and complications from cataract surgery. She has co-authored peer-reviewed articles on topics ranging from optical coherence tomography imaging to embryonic stem cells for macular degeneration.
In addition to her clinical practice, she is dedicated to the education and training of medical students, residents, and fellows. As recognition of her efforts, she received the Faculty Teaching Award in 2016 from the Byers Eye Institute at Stanford University and has served as the Associate Residency Program Director since 2020.
Dr. Pan's clinical practice is mainly based at Santa Clara Valley Medical Center, where she is chief of the retina service. -
Suzann Pershing, MD
Associate Professor of Ophthalmology
BioDr. Pershing is on the ophthalmology faculty at Stanford University School of Medicine, with an academic career blending clinical practice, teaching, research, and administration. She serves as Program Director for the Stanford University Medical Center ophthalmology residency and Chief of Ophthalmology for the VA Palo Alto Health Care System.
In her role as residency program director, she is committed to residency program diversity and excited to innovate and implement novel approaches to residency education—such as the 4-year research track residency program (SOAR), opportunities for resident elective scholarly activity, and efforts to develop a valuable internship program for incoming ophthalmology residents at Stanford.
Her research interests focus on improved utilization of big data, biomedical informatics techniques, and evidence-based medicine to study clinical associations and outcomes, health care utilization, disease progression, and cost-effectiveness of ophthalmic treatment, as well as a special interest in the relationship between visual impairment and cognitive impairment. Dr. Pershing is active in big data initiatives and analysis, including collaborative projects at Stanford and serving as site PI for the American Academy of Ophthalmology (AAO) IRIS Registry analytic group at Stanford. She also serves on the American Board of Medical Specialties Database and Information Technology Advisory Committee (DITAC) and is engaged in efforts to use diverse data sources to facilitate improved quality of care, continuing certification, and practice and outcomes assessments. Dr. Pershing is also is involved in health policy efforts, including helping to develop CMS episode-based cost measures for MIPS, and is interested in health care innovation—technology, quality, and delivery systems.
Dr. Pershing serves as faculty advisor for the Alpha Omega Alpha medical honor society Stanford association, with focus on resident initiatives, and mentors both medical students and undergraduate students. -
Ehsan Rahimy
Adjunct Clinical Assistant Professor, Ophthalmology
BioDr. Ehsan Rahimy specializes in the medical and surgical management of diseases affecting the retina, with a clinical expertise in macular degeneration, diabetic retinopathy, retinal detachment, macular hole, macular pucker/epiretinal membranes, and uveitis.
Dr. Rahimy has authored well over 100 peer-reviewed publications, numerous book chapters, as well as other non-peer reviewed literature. He presents regularly at national and international ophthalmic meetings, having contributed over 200 conference abstracts.
He is passionate about the interplay between technology and medicine, and how ongoing advancements will transform healthcare delivery in the near future. Dr. Rahimy is frequently consulted for collaborative research endeavors and advises on numerous early stage companies involved in ophthalmology, telemedicine, A.I., and other medtech innovation.
Dr. Rahimy graduated with highest distinction from the University of Michigan, followed by receiving his medical degree, with high honors, at Baylor College of Medicine. During this time, he was one of a select few junior inductees into the Alpha Omega Alpha (AOA) Honor Society. He went on to complete his ophthalmology residency at the world-renowned Jules Stein Eye Institute at UCLA, recognized as one of the premier residency programs in the country, where he received the Pepose-Saltzman Young Investigator Research Award, Henry & Lilian Nesburn Research Award, and the Devgan Outstanding Surgical Resident Award. Afterwards, he pursued subspecialty training in vitreoretinal surgery at Wills Eye Hospital, considered the preeminent retinal fellowship program in the country, under the guidance and mentorship of many of the field's leaders. While there, he was awarded a Heed Fellowship, the Ronald G. Michels Fellowship Award, and the William B. Tasman Outstanding Fellow Award. -
Tawna L. Roberts, OD, PhD
Assistant Professor of Ophthalmology (Pediatric) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsOur research efforts are funded by grants from the National Eye Institute, Department of Defense, and various foundations to study vision development in infants and young children as well as binocular vision disorders in adolescents and adults with concussions. Our focus is to identify underlying mechanisms that will inform clinical treatment approaches and ultimately leading to the prevention of strabismus, amblyopia, and binocular vision disorders.
-
Jennifer Rose-Nussbaumer
Associate Professor of Ophthalmology
BioJennifer Rose-Nussbaumer is a board-certified ophthalmologist and fellowship-trained cornea specialist at the Byers Eye Institute at Stanford University. Her clinical practice focuses on lamellar keratoplasty such as Descemet Membrane Endothelial Keratoplasty (DMEK), Ultrathin-Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK), and Deep Anterior Lamellar Keratoplasty (DALK), as well as cataract surgery. After completing her fellowship in corneal transplantation at the University of California, San Francisco, she stayed on faculty and remained there until she transitioned to Stanford in 2021.
In addition to her clinical work, Dr. Rose-Nussbaumer is an NIH-funded researcher who focuses on randomized clinical trials in ophthalmology. She is the PI on a UG1 grant, Descemet Endothelial Thickness Comparison Trial (DETECT), a randomized clinical trial comparing UT-DSAEK to DMEK and ripasudil versus placebo in patients with endothelial disease such as Fuchs Endothelial Dystrophy. She is also the PI on a UG1 grant, the Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II), a randomized clinical trial in collaboration with Aravind Eye hospital in India looking at the benefit of adjunctive topical steroids, corneal crosslinking or rose bengal photodynamic therapy in the treatment of infectious ulcers.
As a native of Northern California, she loves spending time with her family and Bernese Mountain Dog, Kenji, exploring California's natural beauty through hiking and camping. -
Daniel Rubin
Professor of Biomedical Data Science, of Radiology (Integrative Biomedical Imaging Informatics at Stanford), of Medicine (Biomedical Informatics Research) and, by courtesy, of Ophthalmology
Current Research and Scholarly InterestsMy research interest is imaging informatics--ways computers can work with images to leverage their rich information content and to help physicians use images to guide personalized care. Work in our lab thus lies at the intersection of biomedical informatics and imaging science.
-
Steven Sanislo, MD
Clinical Professor, Ophthalmology
BioDr Sanislo has over 20 years of experience in clinical and surgical practice in retinal and vitreoretinal diseases. He is the senior vitreoretinal surgeon at Stanford and maintains a large clinical practice as well as teaching ophthalmology residents and retina fellows. He also participates in clincal reasearch for varying retinal conditions. Dr. Sanislo recieved ophthalmology training as a resident here at Stanford, and recieved vitreoretinal training as a fellow at the Cleveland Clinic Foundation.
Research interests include treatment of age-related macular degeneration, diabetic retinopathy and other retinal diseases.
Dr. Sanislo has extensive clinical and surgical experience in the following diseases:
- Age-related macular degeneration
- Posterior uveitis / infectious and inflammatory disease of the posterior segment
- Diabetic retinopathy
- Myopic degeneration / pathologic myopia
- Macular pucker / epiretinal membranes
- Macular hole
- Repair of simple and complex retinal detachments
- Macular edema
- Retinal vascular occlusion -
Yasir Sepah
Assistant Professor (Research) of Ophthalmology
Current Research and Scholarly InterestsYasir's primary focus is on early identification of ocular diseases and objective assessment of response to therapy via biomarker (imaging and molecular) discovery and endpoints development for clinical trials. His lab is also developing and implementing protocols and methods to make decentralized clinical trials in ophthalmology viable.
Yasir is also engaged in developing low-tech, low cost and less intelligent solutions in order to improve patient's access to care. -
Ann Shue, MD
Clinical Assistant Professor, Ophthalmology
Clinical Assistant Professor (By courtesy), PediatricsBio**Dr. Shue is taking new patients for glaucoma, cataracts, and adult strabismus.**
Ann Shue, MD, is a Clinical Assistant Professor of Ophthalmology at Stanford University School of Medicine, where she specializes in glaucoma, pediatric ophthalmology, and adult strabismus, a unique combination of subspecializations practiced by few surgeons worldwide. She is a board-certified ophthalmologist who completed fellowships in glaucoma at Yale University and pediatric ophthalmology and adult strabismus at Duke University. She practices at the Stanford Byers Eye Institute and the Lucile Packard Children's Hospital.
Dr. Shue loves seeing patients of all ages with eye problems big or small, including glaucoma due to any reason, glaucoma suspicion, family history of glaucoma, cataracts, strabismus (eye misalignment) or double vision from any cause, including after eye surgeries. She completed her ophthalmology residency at the University of Pittsburgh and an internal medicine internship at UCSF Fresno. She holds a medical degree from University of California, Irvine and an undergraduate degree in biology from Yale University.
Dr. Shue is a member of the American Glaucoma Society, the American Association for Pediatric Ophthalmology and Strabismus, and the UK Paediatric Glaucoma Society. She is active in presenting at regional and national conferences. She is the author of several journal articles and recently wrote two textbook chapters on pediatric glaucoma and pediatric glaucoma surgery. -
Ruwan Silva, MD, MPhil
Clinical Assistant Professor, Ophthalmology
BioProfessor Ruwan Amila Silva, MD, MPhil is board certified and fellowship trained vitreoretinal surgeon in the department of ophthalmology at Stanford University Medical Center. He received his BA in Neurobiology from Harvard University graduating Magna cum laude with Highest Honors. He then received his Masters of Philosophy (MPhil) in Neurobiology from Cambridge University in England. Following this, he received his medical degree from Stanford University’s School of Medicine. Dr. Silva completed his ophthalmology residency at the Bascom Palmer Eye Institute, the top rated eye hospital in the country. While there he was awarded the Heed Fellowship, the most prestigious national award for ophthalmology residents in the country. Dr. Silva returned to Stanford University to complete his vitreoretinal surgery fellowship where he was awarded the Ronald G. Michels Foundation Award, the nation’s highest honor for a retina surgery fellow. During his fellowship at Stanford he was also awarded the prestigious Evangelos S. Gragoudas Award by the Macula Society. Following fellowship, Dr. Silva remained at Stanford University's School of Medicine as an Assistant Professor of Vitreoretinal Surgery in the Department of Ophthalmology. Since 2015, he has been named one of “America’s Top Ophthalmologists” by Consumers’ Research Council of America. He was also selected as a "Top Ophthalmologist" by the International Association of Ophthalmologists.
Dr. Silva's clinical practice focuses mainly on macular degeneration and retinal vascular disease (such as diabetic retinopathy, retinal vein occlusions and central serous retinopathy). Surgically, he specializes in diseases of the vitreous and retina: including repair of retinal detachments, surgery for the macula (such as treatment of epiretinal membranes and macular holes) and correction of dislocated intraocular lenses. His research interests mainly involve developing novel therapies for these diseases (http://med.stanford.edu/artificial-retina.html) and have resulted in over 50 combined peer-reviewed scientific manuscripts, book chapters and national meeting presentations.
Dr. Silva is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, as well as the American Society of Retina Specialists. He is a Board Certified Diplomate of the American Board of Ophthalmology. -
Kuldev Singh, MD, MPH
Professor of Ophthalmology
Current Research and Scholarly InterestsGlaucoma, clinical epidemiology
-
Stephen Smith, MD
Clinical Assistant Professor, Ophthalmology
Current Research and Scholarly InterestsRESEARCH OVERVIEW
Dr. Smith’s primary professional interest is developing solutions for unmet clinical and surgical vitreoretinal needs. Beginning in medical school, one of his primary focuses has been improving treatment outcomes in patients with retinoblastoma (RB). During his second year in medical school Dr. Smith published a manuscript on a novel technique to reduce the risk of tumor spread following intravitreal drug delivery in patients with RB. His work summarizing published data on tumor spread following intravitreal injection therapy (IVT) for RB has resulted in multiple platform presentations at national and international meetings, including an invited lecture at ARVO 2014. The results of this study influenced the growing trend toward broader acceptance of intravitreal chemotherapy in pediatric patients with treatment-resistant retinoblastoma vitreous seeds. A primary active area of research has included studying and publishing on ocular toxicity that results from the use of intravitreal melphalan and other agents for RB. This work, and subsequent publications from leaders in the field, has led to an increased awareness of ocular toxicity caused by injecting chemotherapeutic agents into the eyes of young children. This highlighted the need for toxicity data on additional chemotherapeutic agents for local delivery. To answer this question, Dr. Smith assembled an excellent group of collaborators and consultants, including internationally known experts at Bascom Palmer, Mayo Clinic, and Emory University. As a resident he secured a highly competitive career starter grant from the Knights Templar Foundation and used that funding and the expertise of his collaborators to carry out preclinical ocular toxicity studies of combination intravitreal chemotherapy for RB. His work in RB has led to a broader recognition of the challenges facing patients with RB who receive IVT and has led to a continued search for optimal local injectable therapies for patients with this disease.
INNOVATION HIGHLIGHTS
In addition to his work in retinoblastoma, Dr. Smith has been actively involved in developing technologies to improve outcomes for patients receiving intravitreal injection therapy (IVT) for macular degeneration, diabetic retinopathy, retinal vein occlusions and more. IVT has become the most common procedure performed by retina specialists in the United States, with an estimated 6 million injections given in the United States alone in 2016. Dr. Smith has co-developed technology that simplifies and streamlines the IVT process, removing barriers to treatment and improving patient outcomes. His work in innovation covers pre-clinical and clinical development work, and has given him expertise in diverse subject areas including fundraising, intellectual property portfolio development, team building, and business administration. He is a co-founder of iRenix Medical, a biotechnology and medical device start-up company committed to improving vision through optimization of the IVT process.
Dr. Smith remains dedicated to helping improve and restore vision and quality of life in patients with vitreoretinal disease. He is currently involved in both medical device and pharmaceutical innovation, and serves as a mentor for the Stanford University Biodesign Innovation Course. -
Gayathri Srinivasan OD, MS
Clinical Associate Professor, Ophthalmology
BioDr. Srinivasan is a Clinical Associate Professor in the Department of Ophthalmology at Stanford University. Her clinical focus is in the management of concussion-related vision disorders. Dr. Srinivasan's research interests are amblyopia, strabismus, and concussion-related vision disorders. She serves as an investigator for ongoing clinical studies in the Vision Development and Oculomotor lab headed by Dr. Tawna Roberts.
